Swiss stocks - Factors to watch on October 27

Avidity Biosciences

27/10/2025 06:00

ZURICH/GDANSK, Oct 27 (Reuters) - Here are some of the main factors that may affect Swiss stocks on Monday:

NOVARTIS AG NOVN.S

   Swiss drugmaker Novartis on Sunday said it agreed to acquire U.S. biotech firm Avidity Biosciences RNA.O for about $12 billion in cash.

ANALYSTS' VIEWS

NOVARTIS AG NOVN.S: JEFFERIES ASSUMES COVERAGE WITH HOLD RATING; TARGET PRICE CHF 110 VS CHF 100

ROCHE HOLDING AG ROG.S: JEFFERIES CUTS TO UNDERPERFORM FROM HOLD; CUTS TARGET PRICE TO CHF 230 FROM CHF 270

ECONOMY

SNB sight deposits due at 0900 GMT.

 (Reporting by Zurich newsroom and Gdansk newsroom)

 ((+41 58 306 7336; zurich.newsroom@thomsonreuters.com))

For Top News in a multimedia Web format on Eikon visit: https://bit.ly/2NDFd6g

FOR RELATED PRICES, NEWS AND OTHER TOPICS, DOUBLE-CLICK ON:
Daily Swiss stock market report in German .SDE
All SMI constituent stocks 0#.SSMI
DJ STOXX index .STOXX
Top 10 STOXX sectors .PGL.STOXXS
Top 10 EUROSTOXX sectors .PGL.STOXXES

Swiss mid-cap index .SSMI
Swiss all-share index .SSHI
Swiss market digest .AD.S
Sector overview CH/SECTOR1
All Swiss news CH
Swiss research news CH-RCH
All equity news E

SPEED GUIDES:  EQUITY, EQUITY/NEWS1, EUR/EQUITY, SWITZERLAND, REUTERS